Sharemaestro Newsreel

Cencora shares rise 3% on beating estimates, raised guidance

Cencora Inc. (NYSE:COR) reported strong third-quarter results, exceeding analyst expectations for both earnings per share and revenue. The company also raised its full-year earnings guidance, leading to a 3.37% increase in pre-market trading. This performance was attributed to a robust pharmaceutical-centric strategy and growth …

Did Cencora Inc (COR) Exceed Expectations with Q3 EPS of $3.94 o

Earnings Flash (COR) Cencora, Inc. Posts Q3 Adjusted EPS $4.48 per Share, vs. FactSet Est of $4.35

HENRY SCHEIN, INC. : JEFFERIES RAISES TARGET PRICE TO $95 FROM $80

Jefferies has increased its target price for HENRY SCHEIN, INC. (HSIC.O) shares to $95 from the previous $80. This update was reported by Reuters on August 5, 2026. The article itself is a brief announcement of this change.

Cencora, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:COR) 2026-08-05

Cencora Earnings: Growth Rebound Helps Recover Some Lost Market Confidence

Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?

Henry Schein Q2 2026 Earnings: Margin Gains Support Higher Guidance

Henry Schein reported strong Q2 2026 results with net sales up 6.7% and GAAP diluted EPS rising to $0.82, driven by internal growth, improved margins, and share buybacks. The company raised its FY2026 guidance for sales growth, non-GAAP diluted EPS, and Adjusted EBITDA growth, …

Cencora (NYSE: COR) director takes 97 RSUs instead of $30,000 cash retainer

Cencora director Ellen Cooper received 97 restricted stock units (RSUs) on July 31, 2026, in lieu of a $30,000 quarterly cash retainer. These RSUs, valued at $311.34 per share, increase her direct holdings to 893 shares, with the shares deferred until she leaves the …

Henry Schein (HSIC) Stock Rises On Margin Gains And Higher Guidance

Why Henry Schein (HSIC) Stock Is Up Today

Henry Schein, Inc. Stock 12‑Month Price Target Raised to $91.69, Implies 6% Upside

Analysts have raised the average 12-month price target for Henry Schein, Inc. (HSIC) stock to $91.69, up from $89.62, implying a potential 6% upside from its Aug. 3 closing price. The consensus rating among 20 analysts remains a "Buy," with forecasts ranging from $64 …

Overland Park company announces layoffs to ‘streamline’ operations

Rx Savings Solutions, an Overland Park-based company specializing in prescription price transparency and owned by McKesson Corporation, has announced layoffs to streamline operations and focus on growth. While the exact number of affected employees was not disclosed, the company has not filed a WARN …

New to The Street Launches 1,000+ Commercial TV Blitz for Synergy CHC ($SNYR), Makers of Focus Factor(R) – Adds NewsOut Video PR Coverage & NYC #1 Market Saturation

New to The Street has launched a significant television commercial campaign for Synergy CHC Corp (NASDAQ:SNYR), makers of Focus Factor®, a leading brain health supplement. The campaign includes over 1,000 commercials on national and local networks, NYC market penetration, NewsOut Video PR coverage, distribution …

Cencora, Inc. (NYSE: COR) grants stock to director in lieu of cash

Cencora, Inc. (NYSE: COR) director Dennis M. Nally received a grant of 113 shares of common stock on July 31, 2026, priced at $311.34 per share. This stock award, valued at $35,000, was issued in lieu of his quarterly cash retainer under the company's …

Guardian Pharmacy Services opens long-term care (LTC) pharmacy in Lexington

Guardian Pharmacy Services has opened its first physical location in Kentucky, Guardian Pharmacy of Kentucky, in Lexington. This new state-of-the-art facility will serve residents in various long-term care communities across the state, enhancing service delivery and providing specialized medication management. The expansion aims to …

Cencora earnings up next as distribution giant eyes rebound

Cencora Inc. is set to report its fiscal third-quarter earnings, with analysts expecting $4.34 per share on $84.36 billion in revenue, reflecting a sequential revenue increase but an earnings decline. The company aims to reassure investors after missing expectations last quarter, with a focus …

FTC takes closer look at Cencora-Covetrus animal health merger, Bloomberg News reports

The U.S. Federal Trade Commission (FTC) is scrutinizing Cencora's proposed $3.5 billion acquisition of Covetrus, which would combine two major suppliers of veterinary products. The antitrust agency has sent information demands to customers and rivals of both companies to assess the deal's potential impact …

Henry Schein, Inc. | HSIC Stock Price & Real-time Quotes

This article provides real-time stock price and financial information for Henry Schein, Inc. (HSIC). It details the current stock price, daily performance, market capitalization, trading volume, and key financial metrics. The page also includes an overview of related news, podcasts, and company profile information …

Henry Schein (Nasdaq: HSIC) lifts Q2 2026 sales to $3.46B and EPS to $0.82

Henry Schein, Inc. reported strong Q2 2026 financial results with net sales increasing to $3,458 million and diluted EPS reaching $0.82, up from $0.70 in Q2 2025. The growth was observed across all segments, with Global Distribution and Value-Added Services leading the way. The …

Henry Schein beats Q2 estimates, raises full-year guidance

Henry Schein Inc. reported strong second-quarter results, exceeding analyst expectations for both earnings per share and revenue. The healthcare solutions provider also raised its full-year adjusted EPS guidance and total sales growth outlook, citing sustained momentum across its businesses and solid operational execution. The …

Akso Health Group (AHG:UR): Stock Price, Quote and News

This article provides an overview of Akso Health Group (AHG:UR), including its stock price, quote, and related news. It appears to be a stub or placeholder page from BNN Bloomberg, indicating that more detailed financial information and news about the company would typically be …

Henry Schein, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026

Henry Schein, Inc. reported strong financial results for the second quarter and first six months of 2026. For the second quarter, sales increased to USD 3,458 million and net income rose to USD 94 million, with diluted EPS at USD 0.82. The company also …

Henry Schein Releases Q2 2026 Financial Results

Henry Schein, Inc. announced its Q2 2026 financial results, with non-GAAP diluted earnings per share of $1.27, slightly exceeding the analyst forecast of $1.26. The company reported revenue of $3.46 billion, a 6.7% increase year-over-year, driven by strong performance in its Global Distribution and …

Grainger's Q2 diluted per-share earnings rise 20.5% to $12.01

Grainger (NYSE: GWW) reported strong second-quarter 2026 results, with net sales increasing 10.3% to $5.0 billion and diluted earnings per share (EPS) rising 20.5% to $12.01. The company's operating margin improved to 16.1%, and it generated $333 million in free cash flow, returning $341 …

Did Henry Schein Inc (HSIC) Just Beat EPS Estimates with Q2 Earnings? GF Score: 81/100, 2.7% Overvalued

Henry Schein Inc (HSIC) reported strong Q2 2026 financial results, surpassing analyst expectations with a 6.7% increase in total net sales and robust growth in both GAAP and non-GAAP EPS. The company's CEO, Fred Lowery, expressed confidence, leading to an upward revision of fiscal …

Henry Schein sales rise 6.7% to $3.5B as 2026 guidance rises

Henry Schein (NASDAQ: HSIC) reported strong second-quarter 2026 financial results, with total net sales increasing 6.7% to $3.5 billion, driven by sustained momentum across its businesses and solid operational execution. GAAP diluted EPS was $0.82, while non-GAAP diluted EPS reached $1.27. The company raised …

Henry Schein (NASDAQ:HSIC) Surprises With Q2 CY2026 Sales

Henry Schein (NASDAQ:HSIC) reported stronger-than-expected Q2 CY2026 results, with sales growing 6.7% year-on-year to $3.46 billion and non-GAAP EPS of $1.27, beating analyst estimates. The company also slightly raised its full-year Adjusted EPS guidance. While long-term revenue growth has been modest, recent performance and …

Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth

Cardinal Health (CAH) is expected to report a year-over-year increase in earnings and revenue for the quarter ended June 2026. The company has a Zacks Rank #2 and a positive Earnings ESP of +1.24%, suggesting a high probability of beating the consensus EPS estimate …

Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs

McKesson (MCK) Q2 Earnings: What To Expect

McKesson (NYSE: MCK) is set to report its Q2 earnings this Wednesday afternoon. Analysts expect the healthcare distributor's revenue to grow 6.5% year on year, a slowdown from the previous year, with general reconfirmation of estimates. The company missed revenue expectations last quarter but …

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Cardinal Health (CAH) closed at $235.60, up 2.42%, outperforming the S&P 500, Dow, and Nasdaq in the recent trading session. Despite a monthly decline, analysts are optimistic about its upcoming earnings report on August 11, 2026, with projected year-over-year growth of 16.35% in EPS …

Cardinal Health Inc. stock underperforms Monday when compared to competitors despite daily gains

Shares of Cardinal Health Inc. (CAH) rose 2.42% on Monday, closing at $235.60, marking its second consecutive day of gains. Despite this increase, the stock underperformed compared to the broader market, as the S&P 500 Index (SPX) climbed 1.48% and the Dow Jones Industrial …

Henry Schein earnings up next: Leadership changes in focus By Investing.com

Henry Schein Inc. is set to announce its second-quarter results, with analysts expecting earnings of $1.24 per share on revenue of $3.37 billion. Investors will closely watch the impact of a recent leadership overhaul, including the integration of its global supply chain and distribution …

Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?

Cencora (COR) is poised to report its third-quarter fiscal 2026 results on August 5th, with analysts predicting revenue of $84.89 billion and earnings of $4.37 per share. The company has a history of beating earnings estimates and is expected to deliver another quarter of …